RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Results from EMPHASIS-HF
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 17
OP 18
DO 10.1177/155989771010010
UL http://mdc.sagepub.com/content/10/10/17.2.abstract
AB In the EMPHASIS-HF trial, the addition of eplerenone to evidence-based therapy improved survival rates for patients with mildly symptomatic systolic heart failure.